(Q37740144)

22 August 2017

1 reference

title

Is there a role for mitomycin C in metastatic colorectal cancer? (English)

1 reference

22 August 2017

1 reference

Anastasios Dimou

1

1 reference

22 August 2017

Kostas N Syrigos

series ordinal

2

1 reference

22 August 2017

Muhammad Wasif Saif

series ordinal

3

1 reference

22 August 2017

language of work or name

English

0 references

publication date

1 June 2010

1 reference

Expert Opinion on Investigational Drugs

22 August 2017

published in

1 reference

22 August 2017

volume

19

1 reference

22 August 2017

issue

6

1 reference

22 August 2017

page(s)

723-735

1 reference

22 August 2017

cites work

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.485191

Possible use of combination chemotherapy with mitomycin C and methotrexate for metastatic breast cancer pretreated with anthracycline and taxanes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.485191

Mitomycin plus vinorelbine salvage chemotherapy in non-small cell lung cancer: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.485191

Therapeutic options in the management of intermediate-risk nonmuscle-invasive bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.485191

MITOMYCINS AND PORFIROMYCIN: CHEMICAL MECHANISM OF ACTIVATION AND CROSS-LINKING OF DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.485191

A MOLECULAR MECHANISM OF MITOMYCIN ACTION: LINKING OF COMPLEMENTARY DNA STRANDS

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.485191

Characterization of p53 wild-type and null isogenic colorectal cancer cell lines resistant to 5-fluorouracil, oxaliplatin, and irinotecan

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.485191

Effects of CPT-11 in combination with other anti-cancer agents in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.485191

Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.485191

Irinotecan and mitomycin C in 5-fluorouracil-refractory colorectal cancer patients. A phase I/II study of the Southern Italy Cooperative Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.485191

Phase II study of irinotecan and mitomycin C in 5-fluorouracil-pretreated patients with advanced colorectal and gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.485191

Phase II study of biweekly irinotecan and mitomycin C combination therapy in patients with fluoropyrimidine-resistant advanced colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.485191

Randomized phase II study of irinotecan plus mitomycin C vs. oxaliplatin plus mitomycin C in patients with advanced fluoropyrimidine/leucovorin-pretreated colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.485191

Mitomycin-C and capecitabine as third-line chemotherapy in patients with advanced colorectal cancer: a phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.485191

Capecitabine and mitomycin C as third-line therapy for patients with metastatic colorectal cancer resistant to fluorouracil and irinotecan

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.485191

A phase II study of UFT and Leucovorin in combination with mitomycin C in patients with metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.485191

Protracted infusional 5-fluorouracil plus high-dose folinic acid combined with bolus mitomycin C in patients with gastrointestinal cancer: a phase I/II dose escalation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.485191

Protracted infusional 5-fluorouracil (5-FU) with bolus mitomycin in 5-FU-resistant colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.485191

5-fluorouracil modulated by leucovorin, methotrexate and mitomycin: highly effective, low-cost chemotherapy for advanced colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.485191

Continuous infusion fluorouracil/leucovorin and bolus mitomycin-C as a salvage regimen for patients with advanced colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.485191

A prospective randomised trial of protracted venous infusion 5-fluorouracil with or without mitomycin C in advanced colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.485191

Phase III study of mitomycin-C with protracted venous infusion or circadian-timed infusion of 5-fluorouracil in advanced colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.485191

Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.485191

Carcinoma-associated hemolytic-uremic syndrome: a complication of mitomycin C chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.485191

Modulation of DNA Topoisomerase I Activity byp53

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.485191

10.1517/13543784.2010.485191

21 January 2018

Identifiers

DOI

1 reference

22 August 2017

1 reference